1800 244 735

Helpline (02) 9874 9777

An active lifestyle may make a difference to HD symptoms

We all know that exercise and staying active are good for everyone, whether or not they are at risk of developing HD. A new study of lifestyle activities in people with the HD mutation suggests that staying active is even more important in HD, and that passive habits – especially during the teenage years – might be one factor that can cause earlier onset of HD symptoms.

Genes, the environment and activity

Symptoms of HD usually develop in a person’s 30s or 40s, and to some extent, this depends on the length of the abnormal CAG repeat expansion within the HD gene. The greater the length of this repeat expansion, the earlier symptoms tend to develop. The time when symptoms actually show up varies between people, however. There is evidence that about 40% of this variation is due to other genetic factors, and about 60% is due to unknown influences in a person’s life or surroundings – which scientists refer to as environmental factors.

There is evidence from research that environmental factors like education, leisure activities and occupation influence other neurological disorders like Alzheimer’s disease and Parkinson’s disease. And in animal studies using mice with HD, research has shown that ‘environmental enrichment’ – giving the mice more stimulating surroundings – delays the onset and slows the progression of the disease.

So, could this be the case for humans? A group of researchers in Australia and New Zealand sought to find out.

The group recruited 154 adult volunteers with symptoms of HD. Their CAG repeat sizes were known. Each completed a questionnaire about their leisure activities at different ages, all prior to when their HD symptoms began. These activities were divided into physical (like walking, running or gardening), intellectual (like reading, drawing or playing board games) and passive (like listening to music, watching TV or talking on the phone).

Participants were also interviewed, often with a family member). The same researcher performed all the interviews, and didn’t know any participants' CAG repeat sizes.

What were their results?

First, they confirmed what we already know – that age of onset for HD symptoms is earlier, on average, for people with longer CAG repeat lengths. This was responsible for about half of the variation in age of symptom onset.

But here’s the new information: age of onset for HD symptoms was earlier in volunteers who had spent more time doing passive things. It didn’t seem to matter whether the passive things were for leisure, non-leisure, or a combination. Interestingly, intellectual and physical activities showed no significant impact on age of onset of HD symptoms. A person’s average level of passivity over a lifetime seemed to be a pretty good predictor of symptom onset, too.

Then they asked whether the timing of activity had an influence on symptom onset age. The best predictor was passive habits as a teenager. In other words, activity within the teenage years is the potentially the most impactful in terms of age of onset of HD symptoms.

Lastly, they wondered whether a person’s CAG repeat length could be directly related to his or her level of passivity. They found that this was the case. In other words, it may be that longer CAG lengths make people behave passively, which then has an influence on when symptoms develop.

What did they conclude?

Passive behaviour might itself actually be a subtle early symptom of HD. And in families where a parent has early-onset symptoms of HD, the home environment might encourage passive behaviour in other family members.

Overall, the researchers calculated that passive rather than active behaviour caused a difference of about 4.6 years in the age when symptoms developed – that’s the maximum that could be ‘rewound’ if an active lifestyle prevents the effect of passive behaviour. The time to maximize this impact would be during teenage years. Studies like PREDICT-HD have shown similar findings in young people at risk for HD who have no obvious symptoms.

Are there problems with the study?

Yes. It’s quite a small number of participants, and whether an activity was classed as being physical, intellectual, or passive depends on the judgement of the researcher. What’s more, a passive lifestyle might just make existing symptoms more obvious, rather than being to blame for them in the first place. People with active lifestyles might have similar same symptoms, but just not be aware of them yet.

The bottom line

Being physically and mentally active in life is good for everyone, and particularly for those at risk of developing HD, because it might affect symptom onset. It’s probably best to start these active lifestyle habits early, not only to help maintain them but also to use that critical window of opportunity that seems to exist in HD. Detailed studies of whether exercise and activity are helpful need to follow, and surely will.

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Updates from the EHDN Meeting 2021

Published date: 28 October, 2021

Last month, the Huntington’s disease (HD) research community, patients and other stakeholders met online at the European Huntington’s disease network (EHDN) conference. Despite the ongoing global pandemic, there is a tremendous amount of work underway in labs and clinics around the world as researchers continue to better understand HD and how we might best treat ... Read more

Real talk: Q&A with Roche about GENERATION-HD1

Published date: 28 September, 2021

At the end of day 1 of the European Huntington’s Disease Network (EHDN) conference, the HDBuzz team (minus one) sat down for a zoom chat with the team at Roche to have a frank, candid discussion about the recent halting of GENERATION-HD1, the Phase 3 clinical trial that was testing the ability of the antisense ... Read more

Another tool in the box: Creation of a molecular “dimmer switch” advances gene editing

Published date: 30 August, 2021

A team of scientists recently created an innovative genetic system where a drug taken by mouth could be used to control the action of a gene editor, like those used in CRISPR systems. This has useful applications for research studies in cells and animals, and perhaps most importantly, could lead to improvements in the safety ... Read more

Unpacking recent gene therapy press

Published date: 16 August, 2021

A recent announcement from Voyager Therapeutics outlined a shift in the company’s strategy towards an exciting new technology for gene therapy delivery. Unfortunately this also means that in the short term, they have dropped previous plans to test an HD gene therapy in people with HD. While this news is disappointing, the decision to embrace ... Read more

Does blood hold the key to testing treatments earlier in HD patients?

Published date: 4 August, 2021

Researchers at Johns Hopkins led by Wenzhen Duan have developed a non-invasive way to track progression of Huntington’s disease (HD) which could be used before patients even start showing symptoms. Using a type of brain scan called an MRI, the researchers have shown that in mouse models of HD they can accurately measure the amount ... Read more

A first for CRISPR gene editing could have wider applications for human disease

Published date: 21 July, 2021

A recent clinical trial successfully tested the safety of CRISPR gene editing to reduce the amount of a toxic protein in patients with Familial Transthyretic (TTR) Amyloidosis. Although this study is unrelated to Huntington’s disease, it’s a first for gene editing, and the results could have implications for HD and other brain disorders. CRISPR-Cas9 Clustered ... Read more